Can you expand on that please.
My estimates are around $16 - 19M for the phase 3 trials.
Co will not rely solely on current cash and future sales to fund these trials. That's too far along the risk curve.
Funds will be raised for the trial IMO and that will be this qtr.
Can you expand on that please.My estimates are around $16 - 19M...
Add to My Watchlist
What is My Watchlist?